发明名称 Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5- yl)piperazine
摘要 <p>1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5- yl)-piperazine or physiologically acceptable salts thereof are used for the manufacture of a medicament for the treatment of anxiety disorders chosen from the group including panic disorders with or without agoraphobia, agoraphobia, obsessive-compulsive spectrum disorders, social phobia, posttraumatic stress disorder, acute stress, generalized-anxiety disorder, bipolar disorders, mania and dementia and substance-related disorders, sexual dysfunctions, eating disorders, obesity, anorexia and fibromyalgia.</p>
申请公布号 SK287851(B6) 申请公布日期 2012.01.04
申请号 SK20010001646 申请日期 2000.05.16
申请人 发明人 BARTOSZYK GERD;SEYFRIED CHRISTOPH;VAN AMSTERDAM CHRISTOPH;BOTTCHER HENNING;SEDMAN EWEN
分类号 A61K31/495;C07D405/12;A61K31/00;A61K31/496;A61P1/14;A61P3/04;A61P15/10;A61P21/00;A61P25/00;A61P25/22;A61P25/28;A61P29/00 主分类号 A61K31/495
代理机构 代理人
主权项
地址